Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility Complex

Scandinavian Journal of Immunology - Tập 57 Số 1 - Trang 11-20 - 2003
Katarina Le Blanc1,2, L Tammik1,2, Berit Sundberg1,2, Stephen E. Haynesworth3, Olle Ringdén1,2
1Centre for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
2Division of Clinical Immunology
3Skeletal Research Center, Department of Biology, Case Western Reserve University, Cleveland, OH, USA

Tóm tắt

AbstractWe aimed to study the effects of mesenchymal stem cells (MSCs) on alloreactivity and effects of T‐cell activation on human peripheral blood lymphocytes (PBLs) in vitro. MSCs were expanded from the bone marrow of healthy subjects. MSCs isolated from second to third passage were positive for CD166, CD105, CD44, CD29, SH‐3 and SH‐4, but negative for CD34 and CD45. MSCs cultured in osteogenic, adipogenic or chondrogenic media differentiated, respectively, into osteocytes, adipocytes or chondrocytes. MSC added to PBL cultures had various effects, ranging from slight inhibition to stimulation of DNA synthesis. The stimulation index (SI = (PBL + MSC)/PBL) varied between 0.2 and 7.3. The SI was not affected by the MSC dose or by the addition of allogeneic or autologous MSCs to the lymphocytes.Suppression of proliferative activity was observed in all experiments after the addition of 10,000–40,000 MSCs to mixed lymphocyte cultures (MLCs). Lymphocyte proliferation was 10–90%, compared with a control MLC run in parallel without MSCs. In contrast, the addition of fewer MSCs (10–1000 cells) led to a less consistent suppression or a marked lymphocyte proliferation in several experiments, ranging from 40 to 190% of the maximal lymphocyte proliferation in control MLCs. The ability to inhibit or stimulate T‐cell alloresponses appeared to be independent of the major histocompatibility complex, as results were similar using ‘third party’ MSCs or MSCs that were autologous to the responder or stimulating PBLs. The strongest inhibitory effect was seen if MSCs were added at the beginning of the 6 day culture, and the effect declined if MSCs were added on day 3 or 5. Marked inhibitory effects of allogeneic and autologous MSCs (15,000) were also noted after mitogenic lymphocyte stimulation by phytohaemagglutinin (median lymphocyte proliferation of 30% of controls), Concanavalin A (56%) and protein A (65%). Little, if any, inhibition occurred after stimulation with pokeweed mitogen. Low numbers of MSCs (150 cells) were unable to inhibit mitogen‐induced T‐cell responses.MSCs have significant immune modulatory effects on MLCs and after mitogenic stimulation of PBL. High numbers of MSCs suppress alloreactive T cells, whereas very low numbers clearly stimulated lymphocyte proliferation in some experiments. The effect of a larger number of MSCs on MLCs seems more dependent on cell dose than histocompatibility and could result from an ‘overload’ of a stimulatory mechanism.

Từ khóa


Tài liệu tham khảo

Trentin JJ., 1970, Regulation of Hematopoiesis, 161

10.1182/blood.V92.8.2609

10.1016/S1074-7613(00)80131-4

10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F

10.1016/0014-5793(96)00240-2

10.1126/science.284.5411.143

10.1016/8756-3282(92)90363-2

10.1016/8756-3282(92)90364-3

10.1002/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7

NovelliE BuyanerD ChopraRet al.Human mesenchymal stem cells can enhance human CD34+cell repopulating of NOD/SCID mice.Blood1998:664a.

Lazarus HM, 1995, Ex vivo expansion and subsequent infusion of human bone marrow‐derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use, Bone Marrow Transplant, 16, 557

10.1200/JCO.2000.18.2.307

10.1016/S0301-472X(00)00482-3

Tse WT, 2000, Bone marrow derived mesenchymal cells suppress T‐cell activation without including allogeneic anergy, Blood, 96, 1034a

10.1089/10430340152480258

10.1016/S0301-472X(00)00635-4

10.1016/S0301-472X(01)00769-X

Klyushnenkova E, 1998, Human mesenchymal stem cells suppress allogeneic T‐cell responses in vitro: implications for allogeneic transplantation, Blood, 92, 642a

McIntosh KR, 1999, Suppression of alloreactive T‐cell responses by human mesenchymal stem cells involves CD8+ cells, Blood, 94, 133a

Lazarus H, 2000, Role of mesenchymal stem cells (MSC) in allogeneic transplantation: early phase I clinical results, Blood, 96, 1691a

10.1007/BF02724045

Mallory FB., 1942, Pathological Techniques, 144

10.1111/j.1399-0039.1977.tb00772.x

10.1084/jem.140.1.1

10.1002/eji.1830080110

Lum LG, 1981, In vitro regulation of immunoglobulin synthesis after marrow transplantation: I. T‐cell and B‐cell deficiencies in patients with and without chronic graft‐versus‐host disease, Blood, 58, 431, 10.1182/blood.V58.3.431.431

Friedenstein AJ, 1970, The development of fibroblast colonies in monolayer cultures of guinea‐pig bone marrow and spleen cells, Cell Tissue Kinet, 3, 393

Möller G., 1970, Induction of DNA synthesis in human lymphocytes: interaction between non‐specific mitogens and antigens, Immunology, 19, 583

Anklesaria P, 1989, Improved hematopoiesis in anemic sl/sld mice by splenectomy and therapeutic transplantation of a hematopoietic microenvironment, Blood, 74, 1144, 10.1182/blood.V74.3.1144.1144

10.4049/jimmunol.152.6.3119

10.1097/00007890-199911150-00024

Kushida T, 2000, Treatment of intractable autoimmune diseases in MRL/ipr mice using a new strategy for allogeneic bone marrow transplantation, Blood, 95, 1862, 10.1182/blood.V95.5.1862.005k27_1862_1868

Almeida‐Porada G, 2000, Co‐transplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation, Blood, 95, 3620, 10.1182/blood.V95.11.3620

Archambault MP, 2000, Allogeneic rat mesenchymal stem cells do not elicit an immune response after implantation in immunocompetent recipients, Blood, 96, 762a

El‐Badri NS, 1998, Osteoblasts promote engraftment of allogeneic hematopoietic stem cells, Exp Hematol, 26, 110

Migliaccio A, 1990, Comparative analysis of hematopoetic growth factor released by stromal cells from normal donors or transplant patients, Blood, 75, 305, 10.1182/blood.V75.1.305.305

O'Flaherty E, 1995, Bone marrow stromal function from patients after bone marrow transplantation, Bone Marrow Transplant, 15, 207

Thông tin
Thông tin xuất bản

Scandinavian Journal of Immunology

Tập 57 Số 1

11-20

Thông tin tác giả